This study investigated demographic trends over time in the use of prescription opioids versus heroin among addicted individuals. ICD9 codes associated with hospitalizations for overdoses from either prescription opioids (POD) or heroin (HOD) were harvested from the Nationwide Inpatient Sample (NIS) for the years 1993 through 2009, inclusive. Population data were taken from U.S. Census statistics. Demographic specific rates of POD and HOD hospital admissions were analyzed to determine if fluctuations in the dynamics of one form of opiate, such as supply-based reduction, are correlated with changes in the rates of overdoses of the other. Dataset includes statistical and demographic data.
Due to constraints in vaccine supply, this agent-based model of COVID-19 transmission was developed to compare the impact of two vaccination strategies: 1) vaccinate more individuals with the first dose of available vaccines and delay the second dose or 2) to continue with the recommended 2-dose series as tested in clinical trials. Model population was stratified into 6 age groups of 0 to 4, 5 to 19, 20 to 49, 50 to 64, 65 to 79, and 80+ years based on United States census data.
Dataset is comprised of heroin overdose-related and prescription opioid overdose-related hospitalization rates for the years 2000 through 2014. Data is derived from the Healthcare Cost and Utilization Project (HCUP) Nationwide Inpatient Sample (NIS). Included are rates by census region and division with separate rates for age and race.
Dataset comprises hospitalization rates for opioid injection-related skin and soft-tissue infections (O-SSTI) correlated with changes in the price and purity of heroin for the years 1993 through 2010, inclusive. Data is derived from the Healthcare Cost and Utilization Project (HCUP) Nationwide Inpatient Sample (NIS) and the Drug Enforcement Administration (DEA) System to Retrieve Information from Drug Evidence (STRIDE) databases for 27 Metropolitan Statistical Areas (MSAs).